Drugs / dualCAR-NK19/70
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05842707 | Jan 2023 → Jan 2028 expected | B-cell non-Hodgkin lymphoma | Aibin Liang，MD，Ph.D. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | dualCAR-NK19/70 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05842707 ↗ |
| Route | Intravenous | “Given by IV (vein)” NCT05842707 ↗ |